Becton Dickinson (BDX) EVP Michael Feld reports RSU vesting and 16,655 shares owned

Rhea-AI Filing Summary

Becton Dickinson & Co executive reports equity award activity. Michael Feld, EVP, CRO & President, Life Sciences, reported transactions in Becton Dickinson & Co common stock on 11/26/2025. He acquired 8,829 shares at a price of $0, reflecting the vesting of restricted stock units granted under the company’s 2004 Employee and Director Equity-Based Compensation Plan.

On the same date, 419 shares were disposed of at $0 to cover withholding taxes related to the vesting of previously reported restricted stock units. After these transactions, Feld directly beneficially owned 16,655 shares of Becton Dickinson & Co common stock.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Feld Michael

Role EVP, CRO & Pres. Life Sciences

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	8,829	$0.00	--
Tax Withholding	Common Stock	419	$0.00	--

Holdings After Transaction: Common Stock — 17,074 shares (Direct)

Footnotes (1)

1. Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. Represents shares withheld for payment of withholding taxes in connection with the vesting of restricted stock units previously reported on Table I.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Feld Michael

(Last) (First) (Middle)

C/O BECTON, DICKINSON AND COMPANY

1 BECTON DRIVE

(Street)

FRANKLIN LAKES NJ 07417

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
BECTON DICKINSON & CO [ BDX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, CRO & Pres. Life Sciences

3. Date of Earliest Transaction (Month/Day/Year)
11/26/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/26/2025		A		8,829(1)	A	$0	17,074	D
Common Stock	11/26/2025		F		419(2)	D	$0	16,655	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.

2. Represents shares withheld for payment of withholding taxes in connection with the vesting of restricted stock units previously reported on Table I.

Remarks:

	Donna Kalazdy, by power of attorney from Michael Feld	12/01/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Becton Dickinson (BDX) report for Michael Feld?

Michael Feld, EVP, CRO & President, Life Sciences at Becton Dickinson & Co (BDX), reported equity award-related transactions on 11/26/2025 involving common stock acquired from restricted stock unit vesting and shares withheld for taxes.

How many Becton Dickinson (BDX) shares did Michael Feld acquire in this Form 4?

Michael Feld acquired 8,829 shares of Becton Dickinson & Co common stock at a price of $0, representing vested restricted stock units under the company’s 2004 equity-based compensation plan.

Why were some Becton Dickinson (BDX) shares disposed of in Michael Feld’s Form 4?

The Form 4 states that 419 shares of Becton Dickinson & Co common stock were withheld to pay withholding taxes in connection with the vesting of previously reported restricted stock units.

How many Becton Dickinson (BDX) shares does Michael Feld own after these transactions?

Following the reported transactions, Michael Feld beneficially owned 16,655 shares of Becton Dickinson & Co common stock in direct ownership.

What compensation plan governed the restricted stock units in this Becton Dickinson (BDX) filing?

The restricted stock units in this filing were awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.

Does this Becton Dickinson (BDX) Form 4 reflect a market purchase or sale by Michael Feld?

No market purchase or sale is described. The Form 4 reflects restricted stock unit vesting and shares withheld for taxes, both reported at a price of $0.